Wellington Management Group
VERA icon

Wellington Management Group’s Vera Therapeutics VERA Stock Holding History

Wellington Management Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$987K Sell
22,990
-36,866
-62% -$1.37M ﹤0.01% 1749
2026
Q1 		$2.41M Buy
59,856
+38,623
+182% +$1.66M ﹤0.01% 1518
2025
Q4 		$1.08M Sell
21,233
-1,506
-7% -$53.5K ﹤0.01% 1705
2025
Q3 		$661K Buy
22,739
+4,227
+23% +$97.8K ﹤0.01% 1852
2025
Q2 		$436K Sell
18,512
-549
-3% -$12.3K ﹤0.01% 1839
2025
Q1 		$458K Buy
19,061
+1,043
+6% +$33.5K ﹤0.01% 1834
2024
Q4 		$762K Sell
18,018
-2,053
-10% -$90.9K ﹤0.01% 1771
2024
Q3 		$887K Sell
20,071
-92,568
-82% -$3.51M ﹤0.01% 1735
2024
Q2 		$4.08M Sell
112,639
-18,155
-14% -$720K ﹤0.01% 1366
2024
Q1 		$5.64M Buy
+130,794
New +$4.66M ﹤0.01% 1300
2023
Q4 		– Sell
-84,506
Closed -$1.16M – 1929
2023
Q3 		$1.16M Buy
+84,506
New +$1.45M ﹤0.01% 1582

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group's VERA Position: Q2 2026 in Review

Wellington Management Group reduced its Vera Therapeutics (VERA) stake by 62% in Q2 2026, selling an estimated $1.37M and leaving 22,990 shares worth $987K. The position accounts for ﹤0.01% of the portfolio, ranked #1749.

Wellington Management Group first reported a position in VERA in Q3 2023 and has held it in 11 quarters since. The position peaked at $5.64M in Q1 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Wellington Management Group held 22,990 shares of Vera Therapeutics worth $987K as of Q2 2026.
  • Wellington Management Group sold 36,866 Vera Therapeutics shares in Q2 2026, an estimated $1.37M.
  • Vera Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1749 holding.
  • Wellington Management Group first reported a position in Vera Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • Wellington Management Group's Vera Therapeutics position peaked at $5.64M in Q1 2024.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.